Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?

被引：0
|
作者：
Dhruv Mahtta
Umair Khalid
Arunima Misra
Zainab Samad
Khurram Nasir
Salim S. Virani
机构：
[1] Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality,Health Policy, Quality & Informatics Program
[2] Effectiveness,Department of Medicine, Section of Cardiology
[3] and Safety,Section of Cardiology, Health Services Research and Development (152)
[4] Baylor College of Medicine,Department of Medicine
[5] Michael E. DeBakey Veterans Affairs Medical Center,Methodist DeBakey Heart & Vascular Center
[6] The Aga Khan University,undefined
[7] Houston Methodist Hospital,undefined
来源：
Current Atherosclerosis Reports | 2020年 / 22卷
关键词：
ASCVD; Premature ASCVD; Young; MI; PAD; IHD; ICVD; Gender disparity; Risk prognostication;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] What have we learned?
    Ayres, RU
    [J]. TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 1999, 62 (1-2) : 9 - 12
  • [22] What we have learned
    Macwhinney, Brian
    [J]. JOURNAL OF CHILD LANGUAGE, 2014, 41 : 124 - 131
  • [23] What we have learned
    Zeoli, L
    [J]. JOURNAL OF FORESTRY, 1997, 95 (06) : 35 - 36
  • [24] WHAT HAVE WE LEARNED
    FRANKEL, FH
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 462 : 411 - 415
  • [25] What have we learned?
    Winterbottom, Mark
    [J]. JOURNAL OF BIOLOGICAL EDUCATION, 2021, 55 (02) : 107 - 108
  • [26] WHAT HAVE WE LEARNED
    RAVDIN, IS
    [J]. MILITARY MEDICINE, 1963, 128 (01) : 56 - &
  • [27] WHAT HAVE WE LEARNED
    KLEINE, D
    [J]. JOURNAL OF SOIL AND WATER CONSERVATION, 1995, 50 (04): : 330 - 330
  • [28] Enterprise Modeling - What We Have Learned, and What We Have Not
    Jorgensen, Havard D.
    [J]. PRACTICE OF ENTERPRISE MODELING, PROCEEDINGS, 2009, 39 : 3 - 7
  • [29] Cardiovascular imaging: what have we learned from animal models?
    Santos, Arnoldo
    Fernandez-Friera, Leticia
    Villalba, Maria
    Lopez-Melgar, Beatriz
    Espana, Samuel
    Mateo, Jesus
    Mota, Ruben A.
    Jimenez-Borreguero, Jesus
    Ruiz-Cabello, Jesus
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [30] Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
    Lv, Yue
    Shi, Huiping
    Liu, Hong
    Zhou, Lu
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
12345